Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JYOTHI R MALLEPALLI

Allopathic & Osteopathic Physicians Internal Medicine Rheumatology

NPI
1184635344
CMS profile
189202
Location
MONROE, LA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2019 · Entire year

$3,660.99

257 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2019 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $3,652.70 255
Education $8.29 2

By paying entity

PY2019 · entire year · sorted by reported total

Page 6 of 6; records 251–257 of 257 matching records. This page contains 7 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

JYOTHI R MALLEPALLI

NPI 1184635344 · CMS profile ID 189202

Allopathic & Osteopathic Physicians / Internal Medicine / Rheumatology

MONROE, LA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 6 of 6; records 251–257 of 257 matching records. This page contains 7 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1184635344?year=2019&recipient=provider&page=6#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
JYOTHI R MALLEPALLI, NPI 1184635344, CMS profile ID 189202. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 6 of 6; records 251–257 of 257 matching records. This page contains 7 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1184635344?year=2019&recipient=provider&page=6#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
APA 7
IndustryPayments. (2026). JYOTHI R MALLEPALLI, NPI 1184635344, CMS profile ID 189202. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 6 of 6; records 251–257 of 257 matching records. This page contains 7 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1184635344?year=2019&recipient=provider&page=6#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
Bluebook
JYOTHI R MALLEPALLI, NPI 1184635344, CMS profile ID 189202, IndustryPayments, General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 6 of 6; records 251–257 of 257 matching records. This page contains 7 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e. https://industrypayments.org/provider/npi-1184635344?year=2019&recipient=provider&page=6#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2019 · Physicians and non-physician practitioners · CMS publication 2026-06-30

257 matching records · $3,660.99 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 257 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 251–257 of 257.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Takeda Pharmaceuticals U.S.A., Inc. $10.1501/11/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681999497 CMS
E.R. Squibb & Sons, L.L.C. $11.9201/09/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 651310097 CMS
Novo Nordisk Inc $16.1901/09/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 668770345 CMS
Novartis Pharmaceuticals Corporation $23.6001/08/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 659859027 CMS
Lilly USA, LLC $14.7001/07/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657939785 CMS
Amgen Inc. $12.6401/04/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662585885 CMS
Genentech USA, Inc. $12.0201/02/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681301999 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $3,660.99 257
PY2020 $3,346.28 173
PY2021 $3,208.34 222
PY2022 $3,593.81 214
PY2023 $3,276.60 202
PY2024 $4,405.67 189
PY2025 $3,574.44 196

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $48,138.55 24
PY2024 Principal investigator $64,920.02 16
PY2023 Principal investigator $112,458.14 29
PY2022 Principal investigator $123,154.40 74
PY2021 Principal investigator $120,193.64 69
PY2020 Recipient $746.44 1
PY2020 Principal investigator $163,353.26 89
PY2019 Principal investigator $340,388.47 91

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

24 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ABBVIE INC. $1,046.10 11/04/2025 Non-covered Recipient Entity
THE ARTHRITIS AND DIABETES CLINIC I
A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies) No dispute reported 06/30/2026 1202520227
Principal investigator 1 Janssen Research & Development, LLC $1,014.00 10/31/2025 Non-covered Recipient Entity
ARTHRITIS AND DIABETES CLINIC INC
Guselkumab in Active Psoriatic Arthritis Participants With Inadequate Response/Intolerance to One Prior Anti-TNF Alpha Agent No dispute reported 06/30/2026 1175400643
Principal investigator 1 ABBVIE INC. $1,310.55 10/09/2025 Non-covered Recipient Entity
THE ARTHRITIS AND DIABETES CLINIC I
A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies) No dispute reported 06/30/2026 1202514607
Principal investigator 1 ABBVIE INC. $370.50 09/03/2025 Non-covered Recipient Entity
THE ARTHRITIS AND DIABETES CLINIC I
A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies) No dispute reported 06/30/2026 1202508190
Principal investigator 1 Janssen Research & Development, LLC $2,163.00 08/11/2025 Non-covered Recipient Entity
ARTHRITIS AND DIABETES CLINIC INC
Guselkumab in Active Psoriatic Arthritis Participants With Inadequate Response/Intolerance to One Prior Anti-TNF Alpha Agent No dispute reported 06/30/2026 1175400663
Principal investigator 1 ABBVIE INC. $1,829.75 08/05/2025 Non-covered Recipient Entity
THE ARTHRITIS AND DIABETES CLINIC I
A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies) No dispute reported 06/30/2026 1202502030
Principal investigator 1 Aurinia Pharma U.S., Inc. $2,500.00 07/16/2025 Non-covered Recipient Entity
The Arthritis and Diabetes Clinic, Inc.
LUPKYNIS Registry Study No dispute reported 06/30/2026 1243931266
Principal investigator 1 Aurinia Pharma U.S., Inc. $1,800.00 07/16/2025 Non-covered Recipient Entity
The Arthritis and Diabetes Clinic, Inc.
LUPKYNIS Registry Study No dispute reported 06/30/2026 1243931278
Principal investigator 1 Janssen Research & Development, LLC $712.00 07/07/2025 Non-covered Recipient Entity
ARTHRITIS AND DIABETES CLINIC INC
Guselkumab in Active Psoriatic Arthritis Participants With Inadequate Response/Intolerance to One Prior Anti-TNF Alpha Agent No dispute reported 06/30/2026 1175400649
Principal investigator 1 ABBVIE INC. $501.50 06/03/2025 Non-covered Recipient Entity
THE ARTHRITIS AND DIABETES CLINIC I
A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies) No dispute reported 06/30/2026 1202489813
Principal investigator 1 Janssen Research & Development, LLC $1,424.00 06/02/2025 Non-covered Recipient Entity
ARTHRITIS AND DIABETES CLINIC INC
Guselkumab in Active Psoriatic Arthritis Participants With Inadequate Response/Intolerance to One Prior Anti-TNF Alpha Agent No dispute reported 06/30/2026 1175400669
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $4,500.00 05/20/2025 Non-covered Recipient Entity
Arthritis And Diabetes Clinic
A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjgren's Syndrome (POETYK SjS-1) No dispute reported 06/30/2026 1235998898
Principal investigator 1 ABBVIE INC. $1,652.15 05/06/2025 Non-covered Recipient Entity
THE ARTHRITIS AND DIABETES CLINIC I
A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies) No dispute reported 06/30/2026 1202481877
Principal investigator 1 ABBVIE INC. $559.85 04/03/2025 Non-covered Recipient Entity
THE ARTHRITIS AND DIABETES CLINIC I
A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies) No dispute reported 06/30/2026 1202469323
Principal investigator 1 Janssen Research & Development, LLC $2,270.00 03/31/2025 Non-covered Recipient Entity
ARTHRITIS AND DIABETES CLINIC INC
Guselkumab in Active Psoriatic Arthritis Participants With Inadequate Response/Intolerance to One Prior Anti-TNF Alpha Agent No dispute reported 06/30/2026 1175400655
Principal investigator 1 Aurinia Pharma U.S., Inc. $845.00 03/12/2025 Non-covered Recipient Entity
The Arthritis and Diabetes Clinic, Inc.
LUPKYNIS Registry Study No dispute reported 06/30/2026 1243930968
Principal investigator 1 ABBVIE INC. $1,112.80 03/06/2025 Non-covered Recipient Entity
THE ARTHRITIS AND DIABETES CLINIC I
M15-998 - A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies) No dispute reported 06/30/2026 1202458786
Principal investigator 1 Janssen Research & Development, LLC $753.00 03/03/2025 Non-covered Recipient Entity
ARTHRITIS AND DIABETES CLINIC INC
Guselkumab in Active Psoriatic Arthritis Participants With Inadequate Response/Intolerance to One Prior Anti-TNF Alpha Agent No dispute reported 06/30/2026 1175400680
Principal investigator 1 Eli Lilly and Company $11,750.00 02/12/2025 Non-covered Recipient Entity
ARTHRITIS AND DIABETES INC
A RANDOMIZED, CONTROLLED PRAGMATIC PHASE 3B/4 STUDY OF BARICITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS No dispute reported 06/30/2026 1187874961
Principal investigator 1 ABBVIE INC. $373.10 02/05/2025 Non-covered Recipient Entity
THE ARTHRITIS AND DIABETES CLINIC I
M15-998 - A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies) No dispute reported 06/30/2026 1202444638
Principal investigator 1 Janssen Research & Development, LLC $4,509.00 01/27/2025 Non-covered Recipient Entity
ARTHRITIS AND DIABETES CLINIC INC
Guselkumab in Active Psoriatic Arthritis Participants With Inadequate Response/Intolerance to One Prior Anti-TNF Alpha Agent No dispute reported 06/30/2026 1175400675
Principal investigator 1 ABBVIE INC. $1,000.00 01/14/2025 Non-covered Recipient Entity
ARTHRITIS CLINIC THE
Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 18 to 75 Years of Age Treated With Subcutaneous (SC) Injections of ABBV-154 for Moderately to Severely Active Rheumatoid Arthritis (RA) No dispute reported 06/30/2026 1202438197
Principal investigator 1 ABBVIE INC. $792.25 01/02/2025 Non-covered Recipient Entity
THE ARTHRITIS AND DIABETES CLINIC I
M15-998 - A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies) No dispute reported 06/30/2026 1202434267
Principal investigator 1 ABBVIE INC. $3,350.00 01/02/2025 Non-covered Recipient Entity
THE ARTHRITIS AND DIABETES CLINIC I
M23-700 - Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis (SELECT- SWITCH) No dispute reported 06/30/2026 1202434343